24-Month assessment of respiratory function in patients hospitalized for
severe Sars-Cov-2 pneumonia: a follow-up study
Abstract
Background: Long COVID significantly impacts various body
systems, particularly the respiratory system. This study aimed to
analyze the lung ventilatory function and diffusion capacity of patients
with severe SARS-CoV-2 pneumonia at different time points during a
24-month follow-up course. Methods: Ventilatory function and
lung diffusion capacity of the lung were assessed 6, 12, 18, and 24
months after hospital discharge. Patients underwent spirometry and lung
volume measurements. Ventilatory parameters and DLCO and KCO
normalization were defined as achieving values > 80%
predicted. Results: A total of 222 patients admitted to the
Intensive Care Unit (ICU) of the ASST - Spedali Civili di Brescia,
Brescia, Italy, who survived severe SARS-CoV-2 pneumonia were enrolled.
Among the 172 patients who completed the study, 140 (85.59%) achieved
normalization of ventilatory parameters and DLCO and KCO. The median
time to recovery was 4.5 months, and the hazard ratio (HR) reduced by
2% as each year of age increased. The median time to normalize
ventilatory parameters (VC, FVC, FEV 1, Tiffeneau index,
TLC, and KCO) was 1.5 months, while the median time to VA normalization
was 4.5 months. Male gender reduces the normalization odds of the
Tiffeneau index and Alveolar Volume (VA). The median time to DLCO
normalization was 9 months, with HR reduced by 3.1% as each year of age
increased and augmented by 226% in obese subjects.
Conclusions: 24 months after hospital discharge, 19% of
patients had persistent ventilatory and/or diffusive defects. Our study
documented that male sex, age, and obesity impact the normalization odds
of ventilatory function and diffusive capacity of the lung. These
findings underline the chronic nature of lung damage following severe
COVID-19 pneumonia and the need for long-term follow-ups .